Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Revenue

Abera Bioscience AB had revenue of 4.92M SEK in the quarter ending September 30, 2025, with 46.92% growth. This brings the company's revenue in the last twelve months to 17.30M, up 37.23% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.63M with 479.60% growth.

• Revenue (ttm): 17.30M
• Revenue Growth: +37.23%
• P/S Ratio: 7.25
• Revenue / Employee: 3.46M
• Employees: 5
• Market Cap: 125.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.63M	12.11M	479.60%
Dec 31, 2023	2.52M	736.19K	41.18%
Dec 31, 2022	1.79M	609.91K	51.78%
Dec 31, 2021	1.18M	422.43K	55.92%
Dec 31, 2020	755.48K	-745.52K	-49.67%